Skip to main content

Table 2 Univariate analysis of overall survival in PDAC patients

From: Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma

 

No. of patients

HR (95% CI)

P value

Age

226

0.98 (0.96–1.01)

0.189

History of diabetes

 

1.33 (0.75–2.33)

0.327

 Yes

44

  

 No

183

  

 Not sure

2

  

TNM stage*

 

1.2 (1–1.45)

0.046

 IA

28

  

 IB

77

  

 IIA

16

  

 IIB

89

  

 III

19

  

ECM subtype

 

1.33 (0.97–1.82)

0.076

 Deserted

48

  

 Inter

77

  

 Reactive

85

  

Proteomic subtype*

 

1.5 (1.09–2.06)

0.012

 S-I

57

  

 S-II

106

  

 S-III

54

  

Immune subtype**

 

0.38 (0.2–0.7)

0.002

 Im-S-I

9

  

 Im-S-II

15

  

 Im-S-III

9

  

 Im-S-IV

8

  

 Im-S-V

13

 Â